Delivery Order SPE2DB24D9802-SPE2DB25FJKVQ
Award Date
3/20/25
Potential Completion Date
3/21/25
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Medical Supply Chain division. The single-award indefinite delivery contract (IDC) has a ceiling value of $5,534.45 and runs through July 1, 2024. This order is part of a larger $499,999,999 IDC held by DMS Pharmaceutical Group, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $12,021.90, is for the delivery of 4,564,938,176 units of ondansetron hydrochloride 4 mg tablets to DLA facilities. This contract is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, which allows for the provision of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,003.65 contract is for the delivery of 4,564,668,857 units of ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of May 21, 2024 and was awarded on May 20, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,083.86 firm fixed-price contract is for the delivery of 4565006417 Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,994.48 firm fixed-price delivery order is for the supply of Ondansetron 8mg tablets to support the recurring medical needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $14,027.16 for the supply of 4 mg ondansetron hydrochloride tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an indefinite delivery contract (IDC) valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,476.19 contract is for the supply of Ondansetron ODT 4 mg tablets. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order worth $4,664.96, is for the provision of Ondansetron ODT 4 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...